After ruining 75M J&J doses, Emergent gets FDA clearance for 25M doses – Ars Technica

Enlarge/ The Emergent BioSolutions plant, a manufacturing partner for Johnson & Johnson’s COVID-19 vaccine, in Baltimore, Maryland, on April 9, 2021.
45 with 30 posters participating
View more… [+4742 chars]